Company Profiles

driven by the PitchBook Platform

Diagnostic anSERS

Diagnostic anSERS
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
$500k LATEST DEAL AMOUNT
$1.1M TOTAL AMOUNT RAISED
Description

Producer of ink-jet printed SERS substrates. The company's ink-jet printed SERS substrates helps in rapid field-based materials authentication and trace detection of explosives, narcotics and a wide variety of other residues and contaminants. It helps in solving inherent needs in the market, starting with a roadside marijuana (THC) test for law enforcement.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Commercial Products
Primary Office
5000 College Avenue
Suite 3122
College Park, MD 20740
United States

+1 (301) 886-0280
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Diagnostic anSERS’s full profile, request a free trial.

Diagnostic anSERS Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 08-Dec-2016 $500k $1.1M Completed Generating Revenue
4. Grant 07-Sep-2015 00000 00000 Completed Generating Revenue
3. Grant 20-Jul-2015 00000 00000 Completed Generating Revenue
2. Grant 20-Feb-2013 $135k $100k Completed Generating Revenue
1. Early Stage VC 15-Feb-2013 $100k $100k Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Diagnostic anSERS Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Maryland Industrial Partnerships Accelerator/Incubator 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0

Diagnostic anSERS Executive Team (3)

Name Title Board
Seat
Contact
Info
Eric Hoppmann Ph.D Co-Founder & President
Wei Yu Ph.D Co-Founder & Lead Scientist
Sean Virgile Ph.D Co-Founder